Muscarinic receptors and chronic obstructive pulmonary disease: From Biology to clinical practice
DOI:
https://doi.org/10.11606/issn.1679-9836.v95i3p128-132Keywords:
Pulmonary disease, chronic obstructive, Receptors, muscarinic, Biology.Abstract
The chronic obstructive pulmonary disease (COPD) is characterized by persistent and often progressive airflow limitation associated with a chronic severe inflammatory response in the airways and lungs in response to noxious particles or gases. The prescription of drugs such a muscarinic antagonist is an important step for pulmonary rehabilitation in patients with COPD because they improve symptoms, particularly dyspnea and the ability to do daily activities. There is evidence of some studies also tend to reduce exacerbations. There is no evidence that bronchodilators reduce systemic complications, comorbidities or have influence on mortality.Downloads
Download data is not yet available.
Downloads
Published
2016-12-15
Issue
Section
Artigos
How to Cite
Rodrigues, L. U., Soares, C. T., Venuto, D. B., Santana, R. G., Xavier, A. R., Silva Junior, C. T. da, & Araujo, E. G. de. (2016). Muscarinic receptors and chronic obstructive pulmonary disease: From Biology to clinical practice. Revista De Medicina, 95(3), 128-132. https://doi.org/10.11606/issn.1679-9836.v95i3p128-132